Zelira Therapeutics Limited (ZLDAF)

USD 0.3

(-10.08%)

Revenue Summary of Zelira Therapeutics Limited

  • Zelira Therapeutics Limited's latest annual revenue in 2024 was 94.95 Thousand AUD , down -68.47% from previous year.
  • Zelira Therapeutics Limited's latest quarterly revenue in 2024 FY was 94.95 Thousand AUD , down -68.47% from previous quarter.
  • Zelira Therapeutics Limited reported a annual revenue of 301.12 Thousand AUD in annual revenue 2023, down -80.45% from previous year.
  • Zelira Therapeutics Limited reported a annual revenue of 1.54 Million AUD in annual revenue 2022, up 132.26% from previous year.
  • Zelira Therapeutics Limited reported a quarterly revenue of 54.72 Thousand AUD for 2024 Q2, up 100.0% from previous quarter.
  • Zelira Therapeutics Limited reported a quarterly revenue of 94.95 Thousand AUD for 2024 FY, down -68.47% from previous quarter.

Annual Revenue Chart of Zelira Therapeutics Limited (2024 - 2004)

Historical Annual Revenue of Zelira Therapeutics Limited (2024 - 2004)

Year Revenue Revenue Growth
2024 94.95 Thousand AUD -68.47%
2023 301.12 Thousand AUD -80.45%
2022 1.54 Million AUD 132.26%
2021 663.31 Thousand AUD 0.0%
2020 - AUD -100.0%
2019 769.03 Thousand AUD 145.1%
2018 313.75 Thousand AUD 213.63%
2017 100.04 Thousand AUD -66.65%
2016 300 Thousand AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%
2013 - AUD 0.0%
2012 - AUD 0.0%
2011 - AUD -100.0%
2010 34.25 Thousand AUD 0.0%
2009 - AUD 0.0%
2008 - AUD -100.0%
2007 21.07 Million AUD 14882.59%
2006 140.69 Thousand AUD -75.29%
2005 569.47 Thousand AUD 13.66%
2004 501.04 Thousand AUD 0.0%

Peer Revenue Comparison of Zelira Therapeutics Limited

Name Revenue Revenue Difference
Bioxytran, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.398%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.558%
Intellipharmaceutics International Inc. 65.72 Thousand USD -44.462%
Evofem Biosciences, Inc. 18.21 Million USD 99.479%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.923%
Propanc Biopharma, Inc. - USD -Infinity%
Marizyme, Inc. 645.81 Thousand USD 85.297%
Genus plc 668.8 Million USD 99.986%
Pharming Group N.V. 245.31 Million USD 99.961%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 4.083%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 76.85%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -23.698%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -140.275%
ONE Bio Corp. 52.29 Million USD 99.818%
RVL Pharmaceuticals plc 49.72 Million USD 99.809%
Mesoblast Limited 5.9 Million USD 98.391%
MultiCell Technologies, Inc. 49.32 USD -192422.303%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.679%
Genscript Biotech Corporation 839.52 Million USD 99.989%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -438.857%
Biomind Labs Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 82.975%
Oncotelic Therapeutics, Inc. 70 Thousand USD -35.646%
Skye Bioscience, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -25.392%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 85.581%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -94.176%
Q BioMed Inc. 284.35 Thousand USD 66.608%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.935%
Enzolytics Inc. 52.79 Thousand USD -79.847%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 84.396%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.992%
Northwest Biotherapeutics, Inc. 1.93 Million USD 95.085%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -9404.705%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 32.294%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 84.62%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 90.483%
Capstone Therapeutics Corp. 48.35 Million USD 99.804%
Kadimastem Ltd - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 99.431%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 59.861%
Regen BioPharma, Inc. 236.56 Thousand USD 59.861%
Affymax, Inc. 1.36 Million USD 93.064%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.781%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 79.957%
SYBLEU INC 11.69 Thousand USD -711.833%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -630.4%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -140.178%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 97.149%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 98.575%
IntelGenx Technologies Corp. 1.03 Million USD 90.861%
Gelesis Holdings, Inc. 25.76 Million USD 99.631%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 87.424%